Impact of breast surgery on survival in patients with distant metastases at initial presentation: a systematic review of the literature
- 13 December 2009
- journal article
- review article
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 120 (1) , 9-16
Abstract
According to current treatment standards, patients with metastatic breast cancer at diagnosis receive palliative therapy. Local treatment of the breast is only recommended if the primary tumor is symptomatic. Recent studies suggest that surgical removal of the primary tumor has a favorable impact on the prognosis of patients with primary metastatic breast cancer. We performed a systematic review of the literature to weigh the evidence for and against breast surgery in this patient group. Ten retrospective studies were found in which the use of breast surgery in primary metastatic breast cancer and its impact on survival was examined. The hazard ratios of the studies were pooled to provide an estimate of the overall effect of surgery, and the results and conclusions of the studies were analyzed. A crude analysis, without adjustment for potential confounders, showed that surgical removal of the breast lesion in stage-IV disease was associated with a significantly higher overall survival rate in seven of the ten studies, and a trend toward a better survival in the three remaining studies. Surgery of the primary tumor appeared to be an independent factor for an improved survival in the multivariate analyses from the individual studies, with hazard ratios ranging from 0.47 to 0.71. The pooled hazard ratio for overall mortality was 0.65 (95% CI 0.59–0.72) in favor of the patients undergoing surgery. This systematic review of the literature suggests that surgery of the primary breast tumor in patients with stage-IV disease at initial presentation does have a positive impact on survival. In order to provide a definite answer on whether local tumor control in patients with primary metastatic disease improves survival, a randomized controlled trial comparing systemic therapy with and without breast surgery is needed.Keywords
This publication has 29 references indexed in Scilit:
- Treatment of metastatic breast cancer: looking towards the futureBreast Cancer Research and Treatment, 2008
- Association of Surgery With Improved Survival in Stage IV Breast Cancer PatientsAnnals of Surgery, 2008
- Paclitaxel plus Bevacizumab versus Paclitaxel Alone for Metastatic Breast CancerNew England Journal of Medicine, 2007
- Surgical Resection of the Primary Tumor is Associated with Increased Long-Term Survival in Patients with Stage IV Breast Cancer after Controlling for Site of MetastasisAnnals of Surgical Oncology, 2007
- Trends in the prognosis of patients with primary metastatic breast cancer diagnosed between 1975 and 2002The Breast, 2007
- Surgical Removal of the Primary Tumor Increases Overall Survival in Patients With Metastatic Breast Cancer: Analysis of the 1988–2003 SEER DataAnnals of Surgical Oncology, 2007
- Complete Excision of Primary Breast Tumor Improves Survival of Patients With Metastatic Breast Cancer at DiagnosisJournal of Clinical Oncology, 2006
- Effect of Primary Tumor Extirpation in Breast Cancer Patients Who Present With Stage IV Disease and an Intact Primary TumorAnnals of Surgical Oncology, 2006
- Breast carcinoma survival in Europe and the United StatesCancer, 2003
- Does aggressive local therapy improve survival in metastatic breast cancer?Surgery, 2002